Sign In

Dr. Anthony Lawrence

Chief Strategy & Marketing Officer, ASEAN, Korea, and ANZ

Dr. Anthony Lawrence is a seasoned business leader currently serving as the Chief Strategy & Marketing Officer at GE HealthCare.1 With extensive experience in strategy formulation, he has established himself as a prominent figure in the healthcare industry.1

Professional Background

Dr. Lawrence's career at GE HealthCare has been marked by significant achievements and leadership roles. His expertise extends beyond strategy, encompassing marketing and business development in the healthcare sector.1

Education

He holds a degree from The University of Chicago Booth School of Business, which has likely contributed to his strategic acumen and business insights.1

Recent Activities

Dr. Lawrence has been actively engaged in industry events and initiatives:

  1. In June 2023, he attended two events - fitsummit and echelon - where he had the opportunity to meet with numerous promising startups.2

  2. More recently, in August 2024, Dr. Lawrence was involved in a significant business development activity. He was photographed shaking hands with Chris Chiam following the signing of a Memorandum of Understanding (MOU) between GE HealthCare and Roche.3

These activities demonstrate Dr. Lawrence's commitment to staying at the forefront of healthcare innovation and fostering strategic partnerships in the industry.

As the Chief Strategy & Marketing Officer at GE HealthCare, Dr. Anthony Lawrence plays a crucial role in shaping the company's direction and market presence. His LinkedIn profile (username: dranthonylawrence) serves as a platform for professional networking and sharing insights about his work in the healthcare sector.123

Highlights

Aug 29 · linkedin

I had the distinct privilege of presenting at the Hospital Management Asia (HMA) 2024 conference in Indonesia. This year’s event brought over 1,200 healthcare leaders, innovators, and decision-makers together from across the globe.

Asia, like many other rapidly developing nations, faces a unique set of healthcare challenges. With a population of >4 billion, Asia has a unique burden of disease—where infectious diseases like tuberculosis and dengue fever persist alongside rising non-communicable diseases (NCDs) such as diabetes, cardiovascular diseases, and cancer. This dual burden places strain on the healthcare system, requiring innovative solutions that can drive efficiency, enhance patient outcomes, and ultimately save lives. Enabling Connected Care: The GE Healthcare Commitment

During my presentation on "Enabling Connected Care," I discussed how GE HealthCare is at the forefront of transforming the way healthcare is delivered in Indonesia and across Asia. Our commitment is not just to provide state-of-the-art medical devices but to create an interconnected ecosystem where data, technology, and human expertise converge to deliver superior care.

Through our advanced imaging technologies, AI-driven diagnostics, and integrated healthcare solutions, we are empowering clinicians to make faster, more accurate decisions, reducing the time from diagnosis to treatment, and ultimately improving patient outcomes.

The response from our customers and prospects at HMA has been overwhelmingly positive. It’s truly humbling to see the trust and admiration for GE Healthcare products and services. Our booth was a hub of activity, with healthcare leaders expressing their appreciation for how our solutions are helping them navigate the complexities of modern healthcare. The recognition of GE HealthCare as a partner in driving clinical outcomes reinforces our dedication to continuous innovation and collaboration.

At GE Healthcare, we believe in the power of partnerships. We are committed to supporting Indonesia’s healthcare system in tackling its most pressing challenges, from the ongoing battle against infectious diseases to the rise of NCDs.

As we look to the future, our focus remains on enabling connected care that transcends geographical boundaries, bringing world-class healthcare to every corner of Indonesia and beyond. Together, we can create a healthier, more resilient future for all.

Special shout outs to:

Hospital Management Asia - for providing the platform to connect, learn, and grow. Here’s to many more years of collaboration and innovation in healthcare!

Team #GEHC Indonesia – for your tireless work in championing patient outcomes!

#GEHealthcare #HMA2024 #HealthcareInnovation #ConnectedCare #HealthcareinAsia #IndonesiaHealthcare #PatientOutcomes #MedTech #DigitalHealth #HealthcareTransformation #NCDs #HealthcarePartnerships #FutureOfHealthcare #GlobalHealth

Aug 23 · linkedin

The Lancet's Breast Cancer Commission, predicts that by 2040, the global incidence of new cases of breast cancer will be more than 3 million per year, with the greatest rise in low-income and middle-income countries. Breast cancer was the most frequently diagnosed cancer in women (23·8% of 9·7 million new cases) and the leading cause of cancer death in women (15·4% of 4·3 million deaths).

Similarly, lung cancer was the most common cancer diagnosed, accounting for almost 2·5 million (12·4%) of 20 million new cases of cancer in 2022, and responsible for 1·8 million (18·6%) of 9·7 million cancer deaths worldwide. Lung cancer was also the most frequently diagnosed cancer in men (15·3% of 10·3 million new cases) and the leading cause of cancer deaths in men (22·7% of 4·4 million).

That's why I am excited to share that GE HealthCare has signed an memorandum of understanding with Roche, a collaboration that brings together our great companies to advance oncology care access across Southeast Asia, Korea, Australia, and New Zealand.

Our collaboration aims to leverage GE HealthCare’s oncology care pathway with Roche’s advanced pathology lab solutions, including digital pathology. Together, we’re focused on providing more accurate and comprehensive diagnostic solutions across the oncology care continuum.

This partnership isn’t just about technology; it’s about transforming the entire care pathway – from screening to earlier diagnosis, treatment, and monitoring. By enhancing accuracy, fostering multi-disciplinary collaboration, and utilizing AI for advanced image analysis, we’re aiming to set new benchmarks in healthcare accessibility and quality.

Together with Roche, we are working towards creating healthier communities and pushing the boundaries of what’s possible in oncology care.

Onwards and upwards! Special shout-outs to all the people who made this happen!

Thilo B. | Chris Chiam | Reuben Cherian | Amy Lee | Dr Ritoj Goswami #GEHealthCare #RocheDiagnostics #Oncology #PrecisionCare #HealthcareInnovation #DigitalPathology

Related Questions

What are Dr. Anthony Lawrence's key achievements at GE HealthCare?
How did Dr. Anthony Lawrence transition into his role at GE HealthCare?
What events has Dr. Anthony Lawrence recently attended?
What is Dr. Anthony Lawrence's educational background?
How does Dr. Anthony Lawrence contribute to the strategy and marketing at GE HealthCare?
Dr. Anthony Lawrence
Dr. Anthony Lawrence, photo 1
Dr. Anthony Lawrence, photo 2
Add to my network

Location

Singapore, Singapore